Diagnosis of the prostate cancer with PSMA-PET (program ID: 303360)
University Hospital Heidelberg
Uwe HaberkornSpecialized in: nuclear medicine
Department of Nuclear Medicine
- Initial presentation in the clinic
- clinical history taking
- review of medical records
- physical examination
- urological examination
- laboratory tests:
- complete blood count
- general urine analysis
- biochemical blood test
- inflammation markers (CRP, ESR)
- blood coagulation analysis (aPTT, PT, INR)
- tumor markers, PSA
- ultrasound of pelvic organs (abdominal or through rectum)
- PSMA PET-CT
- nursing services
- consultation of related specialists
- treatment by chief physician and all leading experts
- explanation of individual treatment plan
- Medical records
- MRI/CT scan (not older than 3 months)
- Biopsy results (if available)
You may also book
About the department
The Department of Nuclear Medicine at the University Hospital Heidelberg offers the full range of radioisotope diagnostics and treatment of various diseases. The Chief Physician of the department is Prof. Dr. med. Uwe Haberkorn.
The department is equipped with the advanced medical equipment, which provides the most accurate scanning of all anatomical structures and organs of the human body. In the field of treatment, the focus is on oncological, cardiological and neurological diseases. The department's doctors work in accordance with the international standards, therefore, each patient receives high-quality, individualized medical care.
The service range of the department includes:
- Skeletal scintigraphy
- Thyroid scintigraphy
- Renal scintigraphy
- Positron emission tomography (PET)
- Lymphatic vessel scintigraphy
- Lung scintigraphy
- Somatostatin receptor scintigraphy
- Radiation therapy for the treatment of benign and malignant thyroid diseases
- Metaiodobenzylguanidine (MIBG) therapy, for example, for the treatment of pheochromocytomas, paragangliomas, malignant carcinoids, neuroblastomas and unresectable medullary thyroid carcinomas.
- Radioimmunotherapy (for example, in pancreatic tumors, lymphomas, colorectal tumors)
- 90Y-labeled peptide therapy (for example, in neuroendocrine tumors)
- Radionuclide therapy for the treatment of bone metastases
- Ankylosing spondylitis therapy with the help of 224Ra-radium chloride
- Other diagnostic and treatment methods
Education and Professional Career
- 1979 - 1982 Study of Philosophy and German Philology at the Heidelberg University, Study of Human Medicine at the Universities of Marburg, Wuerzburg and Heidelberg.
- 1988 3rd State Examination, Heidelberg University.
- 1988 Intern and admission to medical practice, Heidelberg University.
- 1995 Medical Specialist in Nuclear Medicine.
- 1988 Doctoral thesis defense, Heidelberg University.
- 1996 Habilitation, Heidelberg University.
- Head of the Department of Nuclear Medicine at the University Hospital Heidelberg, as well as the Head of the Nuclear Medicine Clinical Cooperation Unit at the German Cancer Research Center (DKFZ).
- Diagnostics and treatment of thyroid diseases.
- Diagnostics and treatment of cancers.
- Gene transfer as a method for the treatment of malignant tumors.
- The use of tumor-affinity peptides for the diagnostics and treatment of cancers.
- Non-invasive apoptosis diagnostics.
- 1996 Mallinckrodt Prize of the German Society for Nuclear Medicine.
- 1998 1st Prize for Contrast Media Research from the German Radiological Society.
- 2018 Erwin Schrödinger Prize.
Photo: (с) depositphotos